Call 888-647-0579 to speak with an alcohol or drug abuse counselor.

Who Answers?

Cancer Immunotherapy Shows Long-Term Promise In Lung Cancer

New, long-term results from a clinical trial presented today at the 1st European Lung Cancer Conference jointly organized by the European Society for Medical Oncology (ESMO) and the International Association of the Study of Lung Cancer (IASLC) show that MAGE-A3 ASCI (Antigen-Specific Cancer Immunotherapeutic), an immune-boosting treatment for lung cancer patients, reduces the risk of relapse after surgery — to the same extent as chemotherapy but without the side-effects of chemotherapy.

Prof. Johan Vansteenkiste from University Hospital Gasthuisberg in Belgium described the results after 44-months follow-up from a double-blind, placebo-controlled trial in 182 patients with non-small-cell lung cancer — the most common form of the disease.

After complete surgical resection of the tumor, patients were randomly assigned to receive either placebo injections or injections of MAGE-A3 ASCI administered over 27 months (five given at three-week intervals followed by eight given once every three months).

MAGE-A3 is a tumor-specific antigen, expressed in 35-50% of non-small-cell lung cancer, but not on normal cells.

“The aim is to help the body immune system to recognize the MAGE-A3 antigen and therefore eliminate the cancer cells that express MAGE-A3,” explains Prof. Vansteenkiste. “In other words, it is a kind of treatment method that makes the body immune system specifically attack the lung cancer cells.”

After 44 months, 69 of 182 patients had experienced a recurrence of their cancer, including 57 deaths. Those given the MAGE-A3 injections had longer on average before their cancer recurred, were less likely to have any recurrence, and were less likely to die.

“Surgical resection is the standard treatment for patients with early stage lung cancer, but after complete resection about 50% will relapse and die from their cancer,” says Prof. Vansteenkiste. “Postoperative chemotherapy is able to improve cure rates, but is sometimes poorly tolerated by patients recovering from thoracic surgery. In addition, not all patients are fit to receive chemotherapy. This is why the signal from this phase II randomized study is important: the reduction in risk of postoperative cancer relapse is similar to the one obtained with postoperative chemotherapy, while the side-effects of this new strategy are minimal compared to chemotherapy.”

Most patients only experience mild reactions at the injection site and fever within 24 hours of the injection, he explained. “Therefore, it is suitable for long-term maintenance treatment and for most patients, including older patients or patients in weak physical condition after surgery, allowing them to live a normal life whilst on cancer treatment.” A large Phase III trial of the therapy, named MAGRIT, is now underway.

source: http://www.esmo.org/

More Treatment & Detox Articles

Alcohol abuse adds significantly to costs of doing business

Ensuring Solutions has come up with some sobering facts about alcohol abuse and its impact in almost all facets of our society. Excessive alcohol use by employees and their family members has a substantial impact on the cost of doing business. It costs U.S. employers billions in lost productivity and additional health care costs every….

Alcohol Linked to Cancer Risk in Women

Study Shows Even Low-to-Moderate Drinking Raises Risk of Cancer Women who drink as little as one alcoholic beverage a day — be it beer, wine, or hard liquor — have a significantly higher cancer risk than women who don’t drink at all, a study shows. Researchers followed more than 1.2 million middle-aged women for an….

‘Tis the season for an intervention?

The upcoming holiday season can be particularly stressful if you’ll be spending time with a loved one addicted to alcohol or other drugs. You might feel conflicted about family celebrations; holiday gatherings are supposed to be happy times, but yours don’t look like what you see on television. Should you ignore your loved one’s addiction….

Hit the books not the bottle: Reduce binge drinking

Despite the fact that more than 40 percent of college students are binge drinkers, do not let end-of-the-year stress drive you to hit the bottle instead of the books! Binge drinking is defined by the National Institute of Alcohol Abuse and Alcoholism as the consumption of large quantities of alcohol in about two hours, leading….

Youth access to alcohol hurts all Montanans

In Montana, underage drinking is often thought of as a “rite of passage” that every teen goes through. It is seen as a harmless pastime. The exact opposite is true; this “harmless pastime” contributes to more deaths among our youth than any other preventable cause. Recent studies in brain development show that the human brain….